Infection suppresses tumour neovascularization

blocked neoplastic growth in immunocompromised mice by strong suppression of tumour angiogenesis.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Bacterial and protozoan infections have the ability to suppress neoplastic growth, a process assumed to be due to concomitant cell-mediated anti-tumour immunity. In the May Journal of Immunology Christopher Hunter and colleagues from the University of Pennsylvania, Philadelphia show that suppression of tumour neovascularization is a novel mechanism essential for infection-induced resistance to tumours.

Hunter et al injected melanoma cells into normal and immunocompromised mice and found that in both situations an acute infection with Toxoplasma gondii effectively blocked neoplastic growth. In immunocompromised mice the effect was independent of cytotoxic T or NK cells, production of NO by macrophages or the function of the cytokines IL-12 and TNF-α but was accompanied by strong suppression of angiogenesis inside the nascent tumor. This suppression resulted in severe hypoxia and avascular necrosis that arrested neoplastic growth (J Immunol 2001, 166: 5878-5881).

T. gondii is unlikely to be used in the treatment of cancer ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours